
### [NCIT:C40304](http://purl.obolibrary.org/obo/NCIT_C40304)
**Label:** Malignant Vulvar Sweat Gland Neoplasm

**Subclasses:** [NCIT:C4027](http://purl.obolibrary.org/obo/NCIT_C4027) (Paget Disease of the Vulva), [NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma), [NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma), [NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma), [NCIT:C40305](http://purl.obolibrary.org/obo/NCIT_C40305) (Vulvar Eccrine Adenocarcinoma), [NCIT:C128164](http://purl.obolibrary.org/obo/NCIT_C128164) (Vulvar Adenocarcinoma of Sweat Gland Type), 

**Class expressions from DL-Learner:**

- [UBERON:0002330](http://purl.obolibrary.org/obo/UBERON_0002330) (exocrine system) 56.25%
- [UBERON:0002097](http://purl.obolibrary.org/obo/UBERON_0002097) (skin of body) 56.25%
- [UBERON:0000997](http://purl.obolibrary.org/obo/UBERON_0000997) (mammalian vulva) 56.25%
- [UBERON:0000474](http://purl.obolibrary.org/obo/UBERON_0000474) (female reproductive system) 56.25%
- [NCIT:C36156](http://purl.obolibrary.org/obo/NCIT_C36156) (Favorable Clinical Outcome) 56.25%
- Thing 52.26%
- [UBERON:0000990](http://purl.obolibrary.org/obo/UBERON_0000990) (reproductive system) 35.12%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 34.99%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 34.86%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 34.65%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 34.64%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 34.43%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 34.43%
- [UBERON:0001820](http://purl.obolibrary.org/obo/UBERON_0001820) (sweat gland) 28.61%
- [UBERON:0000467](http://purl.obolibrary.org/obo/UBERON_0000467) (anatomical system) 25.41%


